Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Teva
Daiichi Sankyo
Federal Trade Commission
Harvard Business School
AstraZeneca
Julphar
US Department of Justice
Chinese Patent Office

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for Patent: RE38743

« Back to Dashboard

Summary for Patent: RE38743
Title: Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events
Abstract:Heterogeneous intimate admixtures of sulfated heparinic polysaccharides, well suited for the prophylaxis/treatment of acute thrombotic episodes in a human patient, comprise immixture of sulfated polysaccharides having a weight average molecular weight less than that of heparin and which include from 9% to 20% of polysaccharide chains having a molecular weight less than 2,000 daltons and from 5% to 20% of polysaccharide chains having a molecular weight greater than 8,000 daltons, the ratio between the weight average molecular weight and the number average molecular weight thereof ranging from 1.3 to 1.6.
Inventor(s): Debrie; Roger (Pont St Maxence, FR)
Assignee: Aventis Pharma S.A. (Antony, FR)
Application Number:10/430,435
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent RE38743
Patent Claim Types:
see list of patent claims
Process; Compound; Use; Composition;

Drugs Protected by US Patent RE38743

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: RE38743

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France90 08013Jun 26, 1990

International Family Members for US Patent RE38743

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 398976 ➤ Try a Free Trial
Austria A128191 ➤ Try a Free Trial
Australia 643531 ➤ Try a Free Trial
Australia 7928891 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Teva
Dow
Colorcon
Johnson and Johnson
Citi
Chinese Patent Office
Daiichi Sankyo
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.